Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aarti Drugs Ltd.
Swot
Aarti Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aarti Drugs Ltd. has 15 Strengths, 5 Weaknesses, 9 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(5)
Opportunity
(9)
Threats
(1)
Others
(3)
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing profits every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
RSI indicating price strength
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Degrowth in Revenue and Profit
Decline in Quarterly Net Profit (YoY)
Declining Net Cash Flow : Companies not able to generate net cash
Broker price or reco upgrades in last month
Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Broker price or reco upgrades in last month
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
Red Flag: Companies seeing significant coronavirus impact
Rising Delivery Percentage Compared to Prev Day
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
